交易 Incyte Corporation - INCY CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.13 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Incyte Corp ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Jun 7, 2023 | 61.31 | -0.23 | -0.37% | 61.54 | 61.60 | 60.78 |
Jun 6, 2023 | 61.64 | -0.41 | -0.66% | 62.05 | 62.65 | 61.27 |
Jun 5, 2023 | 62.29 | 0.14 | 0.23% | 62.15 | 62.86 | 61.88 |
Jun 2, 2023 | 62.43 | 1.34 | 2.19% | 61.09 | 62.54 | 60.93 |
Jun 1, 2023 | 61.45 | -0.23 | -0.37% | 61.68 | 61.85 | 60.58 |
May 31, 2023 | 61.46 | -0.20 | -0.32% | 61.66 | 62.36 | 61.38 |
May 30, 2023 | 61.81 | -0.25 | -0.40% | 62.06 | 62.61 | 61.21 |
May 26, 2023 | 62.48 | -0.16 | -0.26% | 62.64 | 62.94 | 62.07 |
May 25, 2023 | 62.80 | -0.72 | -1.13% | 63.52 | 63.52 | 62.38 |
May 24, 2023 | 64.23 | -0.12 | -0.19% | 64.35 | 65.06 | 63.65 |
May 23, 2023 | 65.00 | 0.89 | 1.39% | 64.11 | 65.89 | 63.76 |
May 22, 2023 | 64.31 | 0.34 | 0.53% | 63.97 | 64.59 | 63.28 |
May 19, 2023 | 63.48 | -0.06 | -0.09% | 63.54 | 64.25 | 63.21 |
May 18, 2023 | 63.57 | -0.66 | -1.03% | 64.23 | 64.33 | 62.96 |
May 17, 2023 | 64.46 | -0.06 | -0.09% | 64.52 | 64.68 | 63.49 |
May 16, 2023 | 64.65 | -0.55 | -0.84% | 65.20 | 65.69 | 64.63 |
May 15, 2023 | 66.12 | 0.91 | 1.40% | 65.21 | 66.18 | 64.88 |
May 12, 2023 | 65.19 | 1.12 | 1.75% | 64.07 | 65.34 | 63.56 |
May 11, 2023 | 64.09 | 0.30 | 0.47% | 63.79 | 64.12 | 63.38 |
May 10, 2023 | 63.83 | -0.62 | -0.96% | 64.45 | 64.90 | 63.80 |
Incyte Corporation Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Monday, June 12, 2023 | ||
时间(协调世界时) (UTC) 15:40 | 国家/地区 US
| 事件 Incyte Corp at Goldman Sachs Healthcare Conference Incyte Corp at Goldman Sachs Healthcare ConferenceForecast -Previous - |
Wednesday, June 14, 2023 | ||
时间(协调世界时) (UTC) 14:00 | 国家/地区 US
| 事件 Incyte Corp Annual Shareholders Meeting Incyte Corp Annual Shareholders MeetingForecast -Previous - |
Thursday, June 15, 2023 | ||
时间(协调世界时) (UTC) 17:00 | 国家/地区 US
| 事件 Incyte Corp Annual Shareholders Meeting Incyte Corp Annual Shareholders MeetingForecast -Previous - |
Monday, July 31, 2023 | ||
时间(协调世界时) (UTC) 11:00 | 国家/地区 US
| 事件 Q2 2023 Incyte Corp Earnings Release Q2 2023 Incyte Corp Earnings ReleaseForecast -Previous - |
Monday, October 30, 2023 | ||
时间(协调世界时) (UTC) 11:00 | 国家/地区 US
| 事件 Q3 2023 Incyte Corp Earnings Release Q3 2023 Incyte Corp Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 3394.64 | 2986.27 | 2666.7 | 2158.76 | 1881.88 |
收入 | 3394.64 | 2986.27 | 2666.7 | 2158.76 | 1881.88 |
收入成本,共计 | 185.497 | 129.491 | 109.828 | 92.749 | 72.623 |
毛利 | 3209.14 | 2856.78 | 2556.87 | 2066.01 | 1809.26 |
总营业费用 | 2815.2 | 2400.49 | 2930.38 | 1756.75 | 1752.66 |
销售/一般/行政费用,总计 | 1002.14 | 739.56 | 516.922 | 468.711 | 434.407 |
研究与开发 | 1585.94 | 1458.18 | 2215.94 | 1154.11 | 1197.96 |
Depreciation / Amortization | 21.5 | 21.5 | 21.5 | 21.5 | 21.5 |
异常费用(收入) | 20.122 | 51.76 | 66.186 | 19.682 | 26.173 |
营业收入 | 579.44 | 585.777 | -263.676 | 402.006 | 129.223 |
利息收入(费用),非经营净值 | -90.256 | -25.98 | 31.458 | 84.785 | -45.636 |
税前净收入 | 529.116 | 570.444 | -232.218 | 486.791 | 115.347 |
税后净收入 | 340.66 | 948.581 | -295.697 | 446.906 | 109.493 |
未计算非常项目前的净收益 | 340.66 | 948.581 | -295.697 | 446.906 | 109.493 |
净收入 | 340.66 | 948.581 | -295.697 | 446.906 | 109.493 |
普通股股东可获收益 (不含非经常性项目) | 340.66 | 948.581 | -295.697 | 446.906 | 109.493 |
普通股股东可获收益 (含非經常性項目) | 340.66 | 948.581 | -295.697 | 446.906 | 109.493 |
摊薄调整 | |||||
摊薄净收入 | 340.66 | 948.581 | -295.697 | 446.906 | 109.493 |
摊薄后加权平均股 | 223.958 | 222.074 | 218.073 | 217.657 | 215.635 |
扣除特别项目的每股摊薄盈利 | 1.52109 | 4.27146 | -1.35595 | 2.05326 | 0.50777 |
每股正常摊薄盈利 | 1.57893 | 4.42296 | -1.15868 | 2.13628 | 0.62299 |
其他,净值 | 39.932 | 10.647 | 31.76 | ||
非常规项目总计 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 808.673 | 926.7 | 823.303 | 911.397 | 733.235 |
收入 | 808.673 | 926.7 | 823.303 | 911.397 | 733.235 |
收入成本,共计 | 51.422 | 53.763 | 49.284 | 45.236 | 37.214 |
毛利 | 757.251 | 872.937 | 774.019 | 866.161 | 696.021 |
总营业费用 | 783.903 | 856.607 | 684.927 | 656.966 | 616.695 |
销售/一般/行政费用,总计 | 315.606 | 272.819 | 266.46 | 253.277 | 209.584 |
研究与开发 | 406.641 | 501.36 | 384.007 | 347.196 | 353.373 |
Depreciation / Amortization | 5.4 | 5.4 | 5.3 | 5.4 | 5.4 |
异常费用(收入) | 4.834 | 23.265 | -20.124 | 5.857 | 11.124 |
营业收入 | 24.77 | 70.093 | 138.376 | 254.431 | 116.54 |
利息收入(费用),非经营净值 | -5.787 | -16.115 | -1.301 | -25.575 | -47.265 |
其他,净值 | 32.873 | 26.637 | 11.513 | 0.522 | 1.26 |
税前净收入 | 51.856 | 80.615 | 148.588 | 229.378 | 70.535 |
税后净收入 | 21.703 | 28.461 | 112.775 | 161.432 | 37.992 |
未计算非常项目前的净收益 | 21.703 | 28.461 | 112.775 | 161.432 | 37.992 |
净收入 | 21.703 | 28.461 | 112.775 | 161.432 | 37.992 |
普通股股东可获收益 (不含非经常性项目) | 21.703 | 28.461 | 112.775 | 161.432 | 37.992 |
普通股股东可获收益 (含非經常性項目) | 21.703 | 28.461 | 112.775 | 161.432 | 37.992 |
摊薄净收入 | 21.703 | 28.461 | 112.775 | 161.432 | 37.992 |
摊薄后加权平均股 | 225.589 | 224.954 | 224.175 | 223.661 | 222.95 |
扣除特别项目的每股摊薄盈利 | 0.09621 | 0.12652 | 0.50307 | 0.72177 | 0.17041 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | 0.10517 | 0.19374 | 0.43493 | 0.7402 | 0.19728 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 4092.85 | 3118.67 | 2359.89 | 2481.49 | 1832.25 |
现金和短期投资 | 3238.97 | 2348.19 | 1801.38 | 2117.55 | 1438.32 |
现金等价物 | 2951.42 | 2057.44 | 1513.01 | 1832.68 | 1163.98 |
短期投资 | 287.543 | 290.752 | 288.369 | 284.87 | 274.343 |
应收账款总额,净额 | 644.879 | 616.3 | 481.994 | 308.809 | 307.598 |
Accounts Receivable - Trade, Net | 644.879 | 616.3 | 481.794 | 308.409 | 306.898 |
Total Inventory | 41.995 | 27.904 | 16.425 | 11.4 | 6.967 |
Prepaid Expenses | 167.011 | 126.278 | 60.098 | 43.725 | 79.366 |
Other Current Assets, Total | |||||
Total Assets | 5840.98 | 4933.35 | 3560.92 | 3426.75 | 2645.76 |
Property/Plant/Equipment, Total - Net | 765.608 | 751.468 | 588.076 | 406.625 | 319.751 |
Property/Plant/Equipment, Total - Gross | 978.422 | 927.188 | 732.45 | 528.495 | 422.982 |
Accumulated Depreciation, Total | -212.814 | -175.72 | -144.374 | -121.87 | -103.231 |
Goodwill, Net | 155.593 | 155.593 | 155.593 | 155.593 | 155.593 |
Intangibles, Net | 129.219 | 150.755 | 172.291 | 193.828 | 215.364 |
Long Term Investments | 133.676 | 221.266 | 222.301 | 133.657 | 99.199 |
Other Long Term Assets, Total | 564.038 | 535.596 | 62.763 | 55.559 | 23.601 |
Total Current Liabilities | 1157.08 | 854.308 | 631.195 | 513.34 | 425.277 |
Accounts Payable | 277.546 | 172.11 | 98.767 | 83.647 | 103.827 |
Accrued Expenses | 575.634 | 460.262 | 370.729 | 274.741 | 191.572 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 300.718 | 219.301 | 159.415 | 135.988 | 111.182 |
Total Liabilities | 1470.86 | 1163.35 | 949.65 | 828.344 | 719.795 |
Total Long Term Debt | 30.083 | 31.632 | 32.573 | 31.918 | 17.434 |
Long Term Debt | 0 | 0 | 17.434 | ||
Other Liabilities, Total | 283.705 | 277.408 | 285.882 | 283.086 | 277.084 |
Total Equity | 4370.12 | 3770 | 2611.27 | 2598.41 | 1925.97 |
Common Stock | 0.223 | 0.221 | 0.219 | 0.216 | 0.213 |
Additional Paid-In Capital | 4792.04 | 4567.11 | 4352.86 | 4044.49 | 3813.68 |
Retained Earnings (Accumulated Deficit) | -437.214 | -777.874 | -1726.45 | -1430.76 | -1877.76 |
Other Equity, Total | 15.069 | -19.454 | -15.36 | -15.542 | -10.165 |
Total Liabilities & Shareholders’ Equity | 5840.98 | 4933.35 | 3560.92 | 3426.75 | 2645.76 |
Total Common Shares Outstanding | 222.747 | 221.084 | 219.489 | 216.178 | 213.275 |
Current Port. of LT Debt/Capital Leases | 3.179 | 2.635 | 2.284 | 18.964 | 18.696 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 30.083 | 31.632 | 32.573 | 31.918 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 3971.63 | 4092.85 | 3821.11 | 3625.84 | 3288.09 |
现金和短期投资 | 3112.71 | 3238.97 | 2977.12 | 2722.43 | 2544.16 |
现金等价物 | 2821.05 | 2951.42 | 2690.62 | 2435.38 | 2256.76 |
短期投资 | 291.661 | 287.543 | 286.5 | 287.044 | 287.401 |
应收账款总额,净额 | 623.788 | 644.879 | 618.188 | 682.968 | 562.344 |
Accounts Receivable - Trade, Net | 623.788 | 644.879 | 618.188 | 682.968 | 562.344 |
Total Inventory | 40.876 | 41.995 | 45.869 | 54.502 | 35.457 |
Prepaid Expenses | 194.257 | 167.011 | 179.932 | 165.95 | 146.13 |
Total Assets | 5797.62 | 5840.98 | 5510.21 | 5319.04 | 5054.22 |
Property/Plant/Equipment, Total - Net | 767.55 | 765.608 | 742.412 | 748.677 | 756.609 |
Property/Plant/Equipment, Total - Gross | 993.226 | 978.422 | 944.392 | 940.535 | 942.42 |
Accumulated Depreciation, Total | -225.676 | -212.814 | -201.98 | -191.858 | -185.811 |
Goodwill, Net | 155.593 | 155.593 | 155.593 | 155.593 | 155.593 |
Intangibles, Net | 140.658 | 129.219 | 134.603 | 139.987 | 145.371 |
Long Term Investments | 128.313 | 133.676 | 149.124 | 149.784 | 174.681 |
Other Long Term Assets, Total | 633.876 | 564.038 | 507.371 | 499.149 | 533.876 |
Total Current Liabilities | 1006.11 | 1157.08 | 1006.6 | 926.674 | 886.163 |
Accounts Payable | 55.633 | 277.546 | 163.175 | 194.77 | 152.547 |
Accrued Expenses | 559.485 | 575.634 | 555.857 | 493.019 | 455.656 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3.149 | 3.179 | 3.112 | 3.036 | 2.796 |
Other Current Liabilities, Total | 387.844 | 300.718 | 284.452 | 235.849 | 275.164 |
Total Liabilities | 1335.06 | 1470.86 | 1283.56 | 1233.97 | 1191.15 |
Total Long Term Debt | 29.699 | 30.083 | 30.476 | 31.157 | 31.385 |
Capital Lease Obligations | 29.699 | 30.083 | 30.476 | 31.157 | 31.385 |
Other Liabilities, Total | 299.245 | 283.705 | 246.491 | 276.143 | 273.601 |
Total Equity | 4462.57 | 4370.12 | 4226.65 | 4085.06 | 3863.07 |
Common Stock | 0.223 | 0.223 | 0.222 | 0.222 | 0.221 |
Additional Paid-In Capital | 4856.91 | 4792.04 | 4721.17 | 4688.98 | 4625.78 |
Retained Earnings (Accumulated Deficit) | -415.511 | -437.214 | -465.675 | -578.45 | -739.882 |
Other Equity, Total | 20.942 | 15.069 | -29.062 | -25.696 | -23.047 |
Total Liabilities & Shareholders’ Equity | 5797.62 | 5840.98 | 5510.21 | 5319.04 | 5054.22 |
Total Common Shares Outstanding | 223.062 | 222.747 | 222.455 | 221.875 | 221.41 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | 340.66 | 948.581 | -295.697 | 446.906 | 109.493 |
经营活动产生的现金 | 969.941 | 749.488 | -124.599 | 710.656 | 336.227 |
经营活动产生的现金 | 67.855 | 57.844 | 51.807 | 54.533 | 54.969 |
Deferred Taxes | 57.091 | -465.604 | -0.35 | -0.377 | -0.459 |
非现金物品 | 305.525 | 223.236 | 191.382 | 152.299 | 218.763 |
Cash Taxes Paid | 136.242 | 67.731 | 70.712 | 33.553 | 5.417 |
已付现金利息 | 0.396 | 0.194 | 0.239 | 0.268 | |
营运资金的变化 | 198.81 | -14.569 | -71.741 | 57.295 | -46.539 |
投资活动产生的现金 | -78.542 | -207.699 | -269.001 | -87.454 | -86.423 |
资本支出 | -77.833 | -181.006 | -187.379 | -78.064 | -73.483 |
其他投资现金流量项目,总计 | -0.709 | -26.693 | -81.622 | -9.39 | -12.94 |
融资活动产生的现金 | -0.794 | 6.176 | 71.709 | 45.711 | 14.657 |
融资现金流项目 | -59.047 | -50.033 | -37.76 | -16.766 | -15.285 |
股票的发行(报废),净额 | 61.115 | 58.626 | 110.305 | 63.299 | 29.942 |
债务的发行(退还),净额 | -2.862 | -2.417 | -0.836 | -0.822 | 0 |
外汇效应 | 3.355 | -3.57 | 2.949 | -0.192 | 0.091 |
现金净变化 | 893.96 | 544.395 | -318.942 | 668.721 | 264.552 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 21.703 | 340.66 | 312.199 | 199.424 | 37.992 |
Cash From Operating Activities | -105.603 | 969.941 | 686.279 | 389.898 | 215.741 |
Cash From Operating Activities | 19.211 | 67.855 | 49.637 | 32.945 | 16.438 |
Non-Cash Items | 62.242 | 305.525 | 210.782 | 179.981 | 98.899 |
Cash Taxes Paid | 7.107 | 136.242 | 116.537 | 76.464 | 3.472 |
Changes in Working Capital | -186.596 | 198.81 | 73.229 | -54.927 | 60.306 |
Cash From Investing Activities | -28.559 | -78.542 | -57.63 | -29.228 | -16.748 |
Capital Expenditures | -11.906 | -77.833 | -56.56 | -28.749 | -17.006 |
Other Investing Cash Flow Items, Total | -16.653 | -0.709 | -1.07 | -0.479 | 0.258 |
Cash From Financing Activities | 4.009 | -0.794 | 1.686 | 15.997 | 0.096 |
Financing Cash Flow Items | -9.177 | -59.047 | -39.197 | -20.327 | -15.634 |
Issuance (Retirement) of Stock, Net | 13.988 | 61.115 | 42.989 | 37.692 | 16.398 |
Issuance (Retirement) of Debt, Net | -0.802 | -2.862 | -2.106 | -1.368 | -0.668 |
Foreign Exchange Effects | -0.199 | 3.355 | 2.728 | 1.198 | 0.21 |
Net Change in Cash | -130.352 | 893.96 | 633.063 | 377.865 | 199.299 |
Deferred Taxes | -22.163 | 57.091 | 40.432 | 32.475 | 2.106 |
Cash Interest Paid |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Baker Bros. Advisors LP | Hedge Fund | 16.2157 | 36175400 | 20429 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.7121 | 21666645 | 222049 | 2023-03-31 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 8.6658 | 19332310 | -30625 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.1877 | 13803982 | 37668 | 2023-03-31 | LOW |
RBC Global Asset Management (UK) Limited | Investment Advisor | 4.9122 | 10958585 | 2591527 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.1791 | 9323057 | -110307 | 2023-03-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 2.5113 | 5602433 | 1034200 | 2023-03-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7759 | 3961742 | 93329 | 2023-03-31 | LOW |
Invesco Capital Management LLC | Investment Advisor | 1.5731 | 3509328 | 1355697 | 2023-03-31 | LOW |
First Trust Advisors L.P. | Investment Advisor | 1.4523 | 3239934 | -134985 | 2023-03-31 | LOW |
Bellevue Asset Management AG | Investment Advisor | 1.2733 | 2840500 | -116477 | 2023-03-31 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.9934 | 2216141 | 1391714 | 2023-03-31 | LOW |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 0.9631 | 2148481 | 445384 | 2023-03-31 | LOW |
Armistice Capital LLC | Hedge Fund | 0.8391 | 1872000 | 460000 | 2023-03-31 | HIGH |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 0.8172 | 1823031 | 362801 | 2023-03-31 | MED |
Two Sigma Investments, LP | Hedge Fund | 0.8007 | 1786335 | 515038 | 2023-03-31 | HIGH |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.7873 | 1756345 | 196814 | 2023-03-31 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.7541 | 1682329 | 394351 | 2023-03-31 | MED |
T. Rowe Price Associates, Inc. | Investment Advisor | 0.7049 | 1572544 | -108155 | 2023-03-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.6985 | 1558376 | -191491 | 2022-12-31 | LOW |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Incyte Company profile
关于 Incyte Corporation
Incyte公司是一家生物制药公司,专注于治疗药物的发现、开发和商业化。 公司还在其位于瑞士莫尔日的欧洲总部和位于东京的日本办事处开展商业和临床开发业务。 该公司在两个治疗领域开展业务,一个治疗领域是血液/肿瘤学,包括骨髓增生性肿瘤和移植物抗宿主病,以及实体瘤和血液恶性肿瘤。 另一个治疗领域是炎症和自身免疫,其中包括其皮肤病商业特许权。 其血液学和肿瘤学特许经营权包括四种产品,即JAKAFI(鲁索利替尼)、MONJUVI(塔法西他单抗-cxix)/MINJUVI(塔法西他单抗)、PEMAZYRE(培美加提尼)和ICLUSIG(波那提尼),以及其他临床开发项目。 其皮肤科商业特许权包括OPZELURA(ruxolitinib)霜和其他临床开发项目。
Industry: | Biopharmaceuticals |
1801 Augustine Cut-Off
WILMINGTON
DELAWARE 19803
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。